• Vor Bio to Participate in Upcoming Investor Conferences

    Source: Nasdaq GlobeNewswire / 22 Nov 2022 08:00:02   America/New_York

    CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

    Piper Sandler 34th Annual Healthcare Conference
    Presentation: Tuesday, November 29, 2022 at 9:30 am ET
    Location: Lotte New York Palace Hotel, New York, NY

    5th Annual Evercore ISI HealthCONx Virtual Conference
    Fireside chat: Thursday, December 1 at 3:05 pm ET

    The JMP Securities Hematology and Oncology Virtual Summit
    Fireside chat: Tuesday, December 6, 2022 at 1:20 pm ET

    A live webcast and archived replay of the presentation and fireside chats will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/

    About Vor Bio
    Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

    Contact:

    Media & Investors
    Sarah Spencer
    +1 857-242-6076
    sspencer@vorbio.com

     


    Primary Logo

Share on,